The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose metronomic chemotherapy (LDMC) as an efficient treatment option in metastatic breast cancer: Results of an exploratory case-control study.
 
Marco Johannes Battista
Honoraria - AstraZeneca; PharmaMar; Roche Pharma AG; Tesaro
Consulting or Advisory Role - PharmaMar; Roche Pharma AG; Tesaro
Speakers' Bureau - MedConcept
Travel, Accommodations, Expenses - PharmaMar
 
Carola Schnatz
No Relationships to Disclose
 
Katrin Almstedt
Honoraria - Pfizer; Roche Pharma AG
 
Walburgis Brenner
No Relationships to Disclose
 
Anne-Sophie Heimes
No Relationships to Disclose
 
Sandra Nezi-Cahn
No Relationships to Disclose
 
Roxana Schwab
Honoraria - Roche Pharma AG
 
Annette Hasenburg
Stock and Other Ownership Interests - Theraclion
Honoraria - Med Public GmbH; MedConcept; Medicultus Kassel; Medupdate; Pfizer/EMD Serono; PharmaMar; Pierre Fabre; Promedior; Roche Pharma AG; SoftConsultGroup; Streamedup!; Tesaro
Consulting or Advisory Role - PharmaMar; Roche Pharma AG; Tesaro
Research Funding - Celgene (Inst)
 
Marcus Schmidt
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AMGEN; AstraZeneca; Myelo Therapeutics GmbH; Novartis; Pantarhei Bioscience; Pfizer; Roche
Research Funding - AstraZeneca (Inst); BioNTech (Inst); Myelo Therapeutics GmbH (Inst); Pantarhei Bioscience (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Slavomir Krajnak
No Relationships to Disclose